13F filer · CIK 1697748 ↗
ARK Invest
Reported value
$15.40B
+20% on the quarter before
Positions
191
16 new · 7 sold out
Top 10
39.4%
of the value
Est. gain
+$2.21B
on stocks held all quarter
Est. return
+19.6%
on those stocks since Q1 2026
Positions as of Jun 30, 2026, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2026. Striped tiles are options.
Largest buys
Since Q1 2026, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SpaceX~$765.1MNew · 0.0% → 5.0%+4,478,013 shares
- Cerebras Systems~$169.0MNew · 0.0% → 1.1%+764,613 shares
- Alphabet~$114.1MAdded · 1.6% → 2.4%+322,920 shares
- X-Energy Inc~$99.4MNew · 0.0% → 0.6%+5,411,846 shares
- Eli Lilly~$77.5MAdded · 0.1% → 0.6%+64,578 shares
- Nvidia~$69.2MAdded · 1.4% → 1.8%+345,821 shares
- Snowflake~$68.6MNew · 0.0% → 0.4%+269,539 shares
- Kratos Defense~$58.9MAdded · 1.9% → 1.5%+1,181,372 shares
- Amazon~$56.2MAdded · 2.2% → 2.5%+235,894 shares
- Alphabet~$50.1MNew · 0.0% → 0.3%+140,122 shares
Largest sells
Since Q1 2026, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- AMD~$753.1MCut · 4.3% → 5.3%−1,296,411 shares
- Roku~$445.4MCut · 2.8% → 0.5%−3,224,525 shares
- Teradyne~$290.5MCut · 2.9% → 2.0%−600,340 shares
- Twist Bioscience Corp~$184.5MCut · 2.3% → 3.0%−1,792,930 shares
- Crispr Therapeutics Ag~$101.0MCut · 4.2% → 3.4%−1,852,684 shares
- Baidu~$93.5MCut · 1.0% → 0.2%−818,397 shares
- Robinhood~$76.9MCut · 3.2% → 3.4%−767,030 shares
- TSMC~$69.4MCut · 1.6% → 1.5%−145,418 shares
- 10x Genomics Inc~$65.7MCut · 1.9% → 2.5%−1,714,260 shares
- Beam Therapeutics Inc~$65.2MCut · 2.2% → 2.3%−1,898,571 shares
Holdings
As of Jun 30, 2026. Changes are in shares against Mar 31, 2026, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares −2.5% · price +13.1% | 7.5% | $1.16B | +$134.8M | ||||||||
| AMDCommon Stock · shares −48% · price +185.6% | 5.3% | $822.8M | +$534.7M | ||||||||
| SpaceXCommon Stock · shares New | 5.0% | $765.1M | — | ||||||||
| Tempus AICommon Stock · shares +4.3% · price +28.1% | 3.8% | $580.6M | +$122.1M | ||||||||
| RobinhoodCommon Stock · shares −13% · price +44.7% | 3.4% | $525.1M | +$162.2M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares −16% · price +14.7% | 3.4% | $516.0M | +$65.9M | ||||||||
| ShopifyCommon Stock · shares −0.5% · price −3.7% | 3.1% | $474.5M | −$18.5M | ||||||||
| Twist Bioscience CorpCommon Stock · shares −28% · price +116.5% | 3.0% | $468.1M | +$251.9M | ||||||||
| 10x Genomics IncCommon Stock · shares −15% · price +80.6% | 2.5% | $383.5M | +$171.2M | ||||||||
| AmazonCommon Stock · shares +17% · price +14.4% | 2.5% | $379.2M | +$40.8M | ||||||||
| PalantirCommon Stock · shares +3.3% · price −20.2% | 2.4% | $374.8M | −$92.1M | ||||||||
| AlphabetCommon Stock · shares +45% · price +23.2% | 2.4% | $368.6M | +$47.9M | ||||||||
| CoinbaseCommon Stock · shares +5.8% · price −16.3% | 2.4% | $367.1M | −$67.4M | ||||||||
| RobloxCommon Stock · shares +9.7% · price −3.9% | 2.3% | $351.6M | −$12.9M | ||||||||
| Beam Therapeutics IncCommon Stock · shares −16% · price +44.0% | 2.3% | $351.3M | +$107.4M | ||||||||
| TeradyneCommon Stock · shares −48% · price +63.2% | 2.0% | $312.0M | +$120.8M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares +16% · price +32.0% | 1.9% | $285.5M | +$59.5M | ||||||||
| CircleCommon Stock · shares +1.1% · price −34.4% | 1.9% | $285.5M | −$147.8M | ||||||||
| NvidiaCommon Stock · shares +33% · price +14.7% | 1.8% | $276.4M | +$26.6M | ||||||||
| CoreWeaveCommon Stock · shares +4.7% · price +28.5% | 1.7% | $264.5M | +$56.0M | ||||||||
| Deere & CompanyCommon Stock · shares −1.5% · price +12.6% | 1.6% | $249.3M | +$27.9M | ||||||||
| BlockCommon Stock · shares +0.1% · price +26.3% | 1.5% | $235.4M | +$48.9M | ||||||||
| Kratos DefenseCommon Stock · shares +34% · price −29.3% | 1.5% | $233.0M | −$72.1M | ||||||||
| TSMCADR · shares −23% · price +41.3% | 1.5% | $230.3M | +$67.3M | ||||||||
| Natera IncCommon Stock · shares +0.7% · price +35.7% | 1.2% | $187.0M | +$48.9M | ||||||||
| Total · 191 positions | 100% | $15.40B | +$2.21B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2026 to Q2 2026: 173 stocks held throughout, up $2.21B (+19.6%).
- AMD+$534.7M+186%
- Twist Bioscience Corp+$251.9M+116%
- 10x Genomics Inc+$171.2M+81%
- Robinhood+$162.2M+45%
- Tesla+$134.8M+13%
- Coinbase−$67.4M−16%
- Kratos Defense−$72.1M−29%
- Bullish−$80.7M−34%
- Palantir−$92.1M−20%
- Circle−$147.8M−34%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |